PEOPLE - HIG Ventures makes appointment:
This article was originally published in Clinica
Executive Summary
Michael Gutch has been appointed to the life sciences investment team of HIG Ventures (the venture capital wing of HIG Capital). Mr Gutch, who has a PhD in cellular and molecular pathology and an MBA will focus on medical device and biopharma opportunities. He joins the Miami, Florida-based team from Lilly Ventures (Eli Lilly's capital group), where he was a principal.